S Söderhäll

2.5k total citations
34 papers, 1.9k citations indexed

About

S Söderhäll is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, S Söderhäll has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in S Söderhäll's work include Acute Lymphoblastic Leukemia research (10 papers), Connective tissue disorders research (5 papers) and Acute Myeloid Leukemia Research (5 papers). S Söderhäll is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Connective tissue disorders research (5 papers) and Acute Myeloid Leukemia Research (5 papers). S Söderhäll collaborates with scholars based in Sweden, Denmark and Finland. S Söderhäll's co-authors include Tomas Lindahl, Eva Åström, Mats Heyman, Joanna Mazur, Erik Forestier, Jakob Kristinsson, Kjeld Schmiegelow, Marit Hellebostad, Anna Porwit‐MacDonald and Mervi Taskinen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

S Söderhäll

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Söderhäll Sweden 23 712 606 446 440 437 34 1.9k
Hiroaki Goto Japan 22 476 0.7× 485 0.8× 634 1.4× 364 0.8× 256 0.6× 157 1.7k
Maria Moschovi Greece 23 468 0.7× 633 1.0× 297 0.7× 427 1.0× 495 1.1× 104 1.9k
Masue Imaizumi Japan 25 357 0.5× 886 1.5× 818 1.8× 279 0.6× 145 0.3× 101 2.0k
Sílvia Regina Brandalise Brazil 23 489 0.7× 813 1.3× 364 0.8× 408 0.9× 266 0.6× 91 1.8k
G Souillet France 29 444 0.6× 312 0.5× 1.1k 2.4× 448 1.0× 366 0.8× 105 2.8k
Patrick Man Pan Yuen Hong Kong 24 336 0.5× 443 0.7× 557 1.2× 232 0.5× 265 0.6× 63 1.5k
David K. Kalwinsky United States 28 1.9k 2.6× 743 1.2× 1.6k 3.6× 544 1.2× 703 1.6× 70 3.0k
David L. Becton United States 26 330 0.5× 453 0.7× 852 1.9× 335 0.8× 134 0.3× 61 1.9k
Kimikazu Matsumoto Japan 20 370 0.5× 270 0.4× 567 1.3× 237 0.5× 201 0.5× 122 1.3k
Sonja Pavlović Serbia 23 237 0.3× 741 1.2× 371 0.8× 205 0.5× 155 0.4× 180 1.9k

Countries citing papers authored by S Söderhäll

Since Specialization
Citations

This map shows the geographic impact of S Söderhäll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Söderhäll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Söderhäll more than expected).

Fields of papers citing papers by S Söderhäll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Söderhäll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Söderhäll. The network helps show where S Söderhäll may publish in the future.

Co-authorship network of co-authors of S Söderhäll

This figure shows the co-authorship network connecting the top 25 collaborators of S Söderhäll. A scholar is included among the top collaborators of S Söderhäll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Söderhäll. S Söderhäll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindahl, Karin, Andreas Kindmark, Carl‐Johan Rubin, et al.. (2016). Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate. Bone. 87. 11–18. 35 indexed citations
2.
Söderhäll, S, Johan Arvidson, Erik Forestier, et al.. (2015). Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica. 101(1). 68–76. 113 indexed citations
3.
Nordlund, Jessica, Anna Kiialainen, Olof Karlberg, et al.. (2011). Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia. 26(6). 1218–1227. 18 indexed citations
4.
Åström, Eva, Per Magnusson, Staffan Eksborg, & S Söderhäll. (2010). Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta. Acta Paediatrica. 99(12). 1834–1840. 17 indexed citations
5.
Laane, Edward, Katja Pokrovskaja Tamm, Eva Buentke, et al.. (2009). Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death and Differentiation. 16(7). 1018–1029. 176 indexed citations
6.
Schmiegelow, Kjeld, Erik Forestier, Marit Hellebostad, et al.. (2009). Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 24(2). 345–354. 272 indexed citations
7.
Schmiegelow, Kjeld, Erik Forestier, Jakob Kristinsson, et al.. (2008). Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia. 23(3). 557–564. 88 indexed citations
8.
Laane, Edward, E. Björklund, Joanna Mazur, et al.. (2007). Dendritic Cell Regeneration in the Bone Marrow of Children Treated for Acute Lymphoblastic Leukaemia. Scandinavian Journal of Immunology. 66(5). 572–583. 12 indexed citations
10.
Björklund, E., Joanna Mazur, S Söderhäll, & Anna Porwit‐MacDonald. (2003). Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia. 17(1). 138–148. 91 indexed citations
12.
Malec, M, E. Björklund, S Söderhäll, et al.. (2001). Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. Leukemia. 15(5). 716–727. 40 indexed citations
13.
Brock, Penelope, Bénédicte Brichard, Catherine Rechnitzer, et al.. (1996). An increased loading dose of ondansetron: a North European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2. European Journal of Cancer. 32(10). 1744–1748. 15 indexed citations
14.
Heyman, Mats, et al.. (1996). Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia.. Journal of Clinical Oncology. 14(5). 1512–1520. 59 indexed citations
16.
Söderhäll, S, Lennart Iselius, Olle Björk, & Åke Öst. (1991). An unusual chromosome aberration 47,XX,+21,dup(12)(q13→q24),dup(12)(q13→q24) in a girl with down syndrome and acute monocytic leukemia. Cancer Genetics and Cytogenetics. 55(1). 97–100. 2 indexed citations
17.
Lambert, B., J. Lindsten, Magnus Nordenskjöld, et al.. (1982). Smoking and sister chromatid exchange.. PubMed. 109. 401–14. 11 indexed citations
18.
Bredberg, Anders, B. Lambert, & S Söderhäll. (1982). Induction and repair of psoralen cross-links in DNA of normal human and xeroderma pigmentosum fibroblasts. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 93(1). 221–234. 30 indexed citations
19.
Nordenskjöld, Magnus, S Söderhäll, & Peter Moldéus. (1979). Studies of DNA-strand breaks induced in human fibroblasts by chemical mutagens/carcinogens. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 63(2). 393–400. 22 indexed citations
20.
Söderhäll, S & Tomas Lindahl. (1973). Two DNA ligase activities from calf thymus. Biochemical and Biophysical Research Communications. 53(3). 910–916. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026